Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
ILD evolution in patients following treatment change.
| Not evaluated | Sustainability | Aggravation | Improvement | Total | |
|---|---|---|---|---|---|
| bDMARD | |||||
| Rituximab | 5 (25%) | 6 (30%) | 2 (10%) | 7 (35%) | 20 |
| Tocilizumab | 3 (50%) | 0 | 2 (33%) | 1 (17%) | 6 |
| TNF inhibitor | 3 (20%) | 0 | 11 (73%) | 1 (7%) | 15 |
| CsDMARD | |||||
| None | 4 | 0 | 6 | 0 | 10 |
| Methotrexate | 9 (29%) | 8 (26%) | 5 (16%) | 9 (29%) | 31 |
| Sulfasalazine | 1 (14%) | 2 (28%) | 3 (43%) | 1 (14%) | 7 |
bDMARD, biologic disease modifying anti-rheumatoid drugs; csDMARD, synthetic disease modifying anti-rheumatoid drugs.
